Jason S Park

US Patent:

7510363, Mar 31, 2009

Filed:

Feb 26, 2007

Appl. No.:

11/678903

Inventors:

Benjamin Chaoning Liu - Silver Spring MD, US
Jason Jin Park - Baltimore MD, US
Kevin David Bruner - Brooklyn NY, US
Robert Louis Stone - Perry Hall MD, US

Assignee:

Northrop Grumman Systems Corporation - Los Angeles CA

International Classification:

B65B 69/00

US Classification:

414425

Abstract:

A bundle handling device is provided that includes a frame, a body, a scoop, a ramp and a controller. The body is mounted to the frame and includes a first opening through which bundles are loaded and a second opening through which bundles are discharged. The scoop and the ramp are mounted to the body. The scoop covers a substantial portion of the second opening, while the ramp covers the remaining portion. The controller is coupled to a plurality of actuators and a plurality of sensors, and controls the rotation of the body, the opening and closing of the scoop and the opening and closing of the ramp, in order to discharge a metered portion of bundles through the second opening.

US Patent:

20110124965, May 26, 2011

Filed:

May 7, 2009

Appl. No.:

12/991568

Inventors:

Jason Y. Park - Washington DC, US
Larry J. Kricka - Devon PA, US

International Classification:

A61B 1/06
C12Q 1/42
C12Q 1/34
C12Q 1/37
A61K 49/00

US Classification:

600160, 435 772, 424 91

Abstract:

Provided are methods for detecting a disease or a condition in a subject, which disease or condition is known to be characterized by abnormal expression of an enzyme The present methods comprise contacting tissue of the subject with a substrate for the enzyme, the substrate chemiluminescing upon reaction with the enzyme, detecting chemiluminescence in the tissue, and, correlating the chemiluminescence to at least one of the presence or absence of the disease or condition in the subject, the stage of the disease or condition in the subject, or the response of the disease or condition in the subject to a therapy regimen The present invention permits sampling, diagnosis, and surveillance of conditions and diseases that are known to be characterized by abnormal expression of at least one enzyme.